36 results on '"Wang, Eunice S."'
Search Results
2. Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
3. Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
4. CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
5. Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
6. Harnessing the benefits of available targeted therapies in acute myeloid leukaemia
7. A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia
8. PARP goes the weasel! Emerging role of PARP inhibitors in acute leukemias
9. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
10. Beyond midostaurin: Which are the most promising FLT3 inhibitors in AML?
11. Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
12. Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience
13. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
14. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
15. Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
16. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients
17. Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia
18. A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia
19. Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy
20. How we will treat chronic myeloid leukemia in 2016
21. Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age
22. Myelodysplastic syndromes and autoimmune diseases—Case series and review of literature
23. Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function
24. Vascular endothelial growth factor inhibition: Conflicting roles in tumor growth
25. Interpretation of cytogenetic and molecular results in patients treated for CML
26. Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia
27. Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases
28. Acute leukemia with KMT2A rearrangement: A master of disguise
29. Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer
30. Eosinophilia characterized by a rare CCT6B mutation and responsive to tyrosine kinase inhibition: Case report and literature review
31. High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure
32. Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia
33. All-trans-retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis
34. Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells
35. Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature
36. High dose daunorubicin: New standard of care for FLT3 ITD mutant AML
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.